Cargando…
The development of anticholinergics in the management of COPD
Anticholinergics have been used to treat obstructive respiratory disease for many years from historical preparations of the deadly nightshade genus, to the more recent developments of ipratropium, oxitropium, and tiotropium. The medical treatment of airways obstruction has focused on achieving maxim...
Autor principal: | Scullion, Jane E |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2692120/ https://www.ncbi.nlm.nih.gov/pubmed/18044064 |
Ejemplares similares
-
Safety and tolerability of inhalational anticholinergics in COPD
por: Sharafkhaneh, Amir, et al.
Publicado: (2013) -
A systematic review of the cardiovascular risk of inhaled anticholinergics in patients with COPD
por: Hilleman, Daniel E, et al.
Publicado: (2009) -
Bronchodilators in COPD: Impact of β-agonists and anticholinergics on severe exacerbations and mortality
por: Salpeter, Shelley R
Publicado: (2007) -
Matching the Inhaler to the Patient in COPD
por: Peché, Rudi, et al.
Publicado: (2021) -
Relevance of dosage in adherence to treatment with long-acting anticholinergics in patients with COPD
por: Izquierdo, José Luis, et al.
Publicado: (2016)